Why Upexi, Inc.’s (UPXI) Stock Is Down 6.50%
As of Monday, September 28, Upexi, Inc.’s UPXI share price has dipped by 6.50%, which has investors questioning if this is right time to buy.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; and functional mushrooms under the Cure Mushrooms brand. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also focuses on cryptocurrency industry and management of cash assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Tampa, Florida.
Commentary & Analysis
Why Upexi, Inc.’s (UPXI) Stock Is Down 6.14%
As of Wednesday, September 23, Upexi, Inc.’s UPXI share price has dipped by 6.14%, which has investors questioning if this is right time to buy.Michael Rose
Why Upexi, Inc.’s (UPXI) Stock Is Up 7.14%
As of Monday, September 21, Upexi, Inc.’s UPXI share price has surged by 7.14%, which has investors questioning if this is right time to sell.Michael Rose
Why Upexi, Inc.’s (UPXI) Stock Is Up 12.79%
As of Friday, September 18, Upexi, Inc.’s UPXI share price has surged by 12.79%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Upexi, Inc.’s (UPXI) Stock Is Up 13.74%
As of Friday, September 18, Upexi, Inc.’s UPXI share price has surged by 13.74%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | UPXI | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $95.2 | $265.5 | 21% |
|
| Shares Out (Mil) | 72.6 | 33.5 | 56% |
|
| Institutional Ownership | 63.2% | 59.8% | 40% |
|
| Float (Mil) | 65.9 | 44.0 | 53% |
|
| Beta | -0.19 | 0.54 | 4% |
|
| Avg Daily Volume (000s) | 5,356 | 148 | 92% |
|
| Price Change (52-week) |
(79.9%) | 56.1% | 8% |
|
| Growth | UPXI | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 0.7% | (0.1%) | 19% |
|
| Net Income (5yr) | (142.6%) | (8.6%) | 1% |
|
| EPS (5yr) | (23.9%) | (1.3%) | 11 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (71.9%) | (15.9%) | 2% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | ($0.230) | ($0.430) | ($0.130) | |
| Month Ago EPS | ($0.110) | ($0.270) | na | |
| # Rev Up | 1 | 1 | na | |
| # Rev Down | 0 | 0 | na | |
| Three Months Ago EPS | ($0.110) | ($0.165) | na | |
| Year/Year Chg | (32.0%) | (88.9%) | na | |
| Financials | UPXI | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $25 | $650 | 14% |
|
| Net Income (TTM) (Mil) | ($246) | $-0 | 6% |
|
| EPS (TTM) | ($3.873) | $0.000 | 9% |
|
| Operating Cash Flow (TTM) (Mil) | ($21) | $27 | 15% |
|
| Net Cash Flow (TTM) (Mil) | $3 | $1 | 49% |
|
| Long-Term Debt (Q1) (Mil) | $163 | $39 | 48% |
|
| Enterprise Value (Q1) (Mil) | $322 | $379 | 30% |
|
| Valuation | UPXI | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 1.71 | na |
|
| P/E | na | 15.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 0.6 | na |
|
| Ratios | UPXI | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 89.5% | 61.0% | 93% |
|
| Net Margin | (984.3%) | 1.7% | 0% |
|
| ROA | (161.9%) | (0.3%) | 3% |
|
| ROE | na | 0.8% | na |
|
| Liabilities to Assets | 129.9% | 48.9% | 97% |
|
| F-Score | 2 | 4 | 7% |
|
Upexi, Inc. did not pass any screens on 10/1/2026.
